Eloísa Bonfá

17.3k total citations
426 papers, 10.3k citations indexed

About

Eloísa Bonfá is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eloísa Bonfá has authored 426 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 269 papers in Rheumatology, 123 papers in Immunology and 71 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eloísa Bonfá's work include Systemic Lupus Erythematosus Research (227 papers), Monoclonal and Polyclonal Antibodies Research (66 papers) and Autoimmune and Inflammatory Disorders Research (52 papers). Eloísa Bonfá is often cited by papers focused on Systemic Lupus Erythematosus Research (227 papers), Monoclonal and Polyclonal Antibodies Research (66 papers) and Autoimmune and Inflammatory Disorders Research (52 papers). Eloísa Bonfá collaborates with scholars based in Brazil, United States and Argentina. Eloísa Bonfá's co-authors include Eduardo Ferreira Borba, Clóvis A. Silva, Rosa Maria Rodrigues Pereira, Jozélio Freire de Carvalho, Keith B. Elkon, Nádia Emi Aikawa, Sandra Gofinet Pasoto, Bruno Gualano, Ana Cristina de Medeiros Ribeiro and Nathan Brot and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Eloísa Bonfá

410 papers receiving 10.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Eloísa Bonfá	5.8k	3.6k	1.3k	1.3k	1.2k	426	10.3k
David D’Cruz	6.5k 1.1×	4.0k 1.1×	1.7k 1.3×	1.2k 1.0×	1.1k 0.9×	279	10.8k
Graciela S. Alarcón	8.8k 1.5×	3.9k 1.1×	1.2k 0.9×	1.8k 1.4×	1.5k 1.3×	320	12.5k
Roberto Caporali	5.7k 1.0×	2.2k 0.6×	855 0.6×	1.1k 0.9×	1.7k 1.5×	450	10.4k
Gianfranco Ferraccioli	6.0k 1.0×	2.7k 0.7×	1.0k 0.8×	2.1k 1.7×	1.7k 1.5×	370	11.5k
Zahir Amoura	7.3k 1.3×	6.3k 1.7×	1.3k 0.9×	1.8k 1.4×	1.4k 1.2×	424	17.6k
Gwan Gyu Song	3.7k 0.7×	2.9k 0.8×	646 0.5×	1.1k 0.9×	889 0.8×	457	9.1k
Gertjan Wolbink	4.5k 0.8×	4.8k 1.3×	3.0k 2.2×	669 0.5×	1.5k 1.3×	204	10.9k
Bernard Combe	10.1k 1.7×	3.3k 0.9×	1.4k 1.0×	1.8k 1.4×	3.7k 3.2×	481	14.3k
Howard Amital	3.4k 0.6×	2.7k 0.7×	619 0.5×	2.4k 1.9×	911 0.8×	401	11.5k
F.H.J. van den Hoogen	5.2k 0.9×	2.7k 0.7×	1.8k 1.4×	2.9k 2.3×	944 0.8×	250	11.1k

Countries citing papers authored by Eloísa Bonfá

Since Specialization

Citations

This map shows the geographic impact of Eloísa Bonfá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eloísa Bonfá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eloísa Bonfá more than expected).

Fields of papers citing papers by Eloísa Bonfá

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eloísa Bonfá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eloísa Bonfá. The network helps show where Eloísa Bonfá may publish in the future.

Co-authorship network of co-authors of Eloísa Bonfá

This figure shows the co-authorship network connecting the top 25 collaborators of Eloísa Bonfá. A scholar is included among the top collaborators of Eloísa Bonfá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eloísa Bonfá. Eloísa Bonfá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bonfiglioli, Karina Rossi, Nádia Emi Aikawa, Renata Miossi, et al.. (2025). Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study. SHILAP Revista de lepidopterología. 1 indexed citations

Kupa, Léonard de Vinci Kanda, Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, et al.. (2025). Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases. JCR Journal of Clinical Rheumatology. 31(6). e104–e111. 1 indexed citations

Alves, José Leonidas, Emily Figueiredo Neves Yuki, Luciana Parente Costa Seguro, et al.. (2024). Reversibility of pulmonary hypertension in systemic lupus erythematosus after induction immunosuppressive therapy: An inflammatory manifestation?. Lupus. 34(1). 18–27.

Gualano, Bruno, Sofia Mendes Sieczkowska, Ítalo Ribeiro Lemes, et al.. (2023). Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases. Journal of Physical Activity and Health. 20(4). 311–316.

Smaira, Fabiana Infante, Ítalo Ribeiro Lemes, Rafael Pires da Silva, et al.. (2023). No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination. Journal of Physical Activity and Health. 20(10). 980–983. 1 indexed citations

Lopes, Michelle, et al.. (2022). Custeio Baseado em Atividade e Tempo (TDABC) do modelo CEDMAC de terapia assistida para dispensação de medicamentos imunobiológicos para doenças reumatológicas no SUS. 14(3). 224–231. 1 indexed citations

Gualano, Bruno, Ítalo Ribeiro Lemes, Rafael Pires da Silva, et al.. (2022). Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients. Scandinavian Journal of Medicine and Science in Sports. 32(10). 1510–1515. 4 indexed citations

Pereira, Rosa Maria Rodrigues, Valéria F. Caparbo, Lucas Peixoto Sales, et al.. (2022). Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. Clinics. 78. 100150–100150. 1 indexed citations

Pasoto, Sandra Gofinet, Lissiane Karine Noronha Guedes, Ana Cristina de Medeiros Ribeiro, et al.. (2022). Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity. Clinical Rheumatology. 41(7). 2079–2089. 7 indexed citations

10.

Souza, Fernando Henrique Carlos de, et al.. (2022). Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies. Clinics. 77. 100031–100031. 2 indexed citations

11.

Saad, Carla Gonçalves Schahin, Júlio César Bertacini de Moraes, Cláudia Goldenstein‐Schainberg, et al.. (2022). Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis. Joint Bone Spine. 90(1). 105464–105464. 8 indexed citations

12.

Aikawa, Nádia Emi, et al.. (2021). Poor Prognosis of COVID‐19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross‐Sectional Population Study Of 252 119 Patients. ACR Open Rheumatology. 3(11). 804–811. 15 indexed citations

13.

Aikawa, Nádia Emi, et al.. (2021). 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus. Clinical Rheumatology. 41(4). 1079–1085. 7 indexed citations

14.

Bonfá, Eloísa, Laure Gossec, David Isenberg, Zhanguo Li, & Soumya Raychaudhuri. (2020). How COVID-19 is changing rheumatology clinical practice. Nature Reviews Rheumatology. 17(1). 11–15. 25 indexed citations

15.

Pons‐Estel, Guillermo, Manuel F. Ugarte‐Gil, Daniel Wojdyla, et al.. (2020). Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective. RMD Open. 6(1). e001097–e001097. 21 indexed citations

16.

Almaani, Salem, Udayan Bhatt, Cristina Arriens, et al.. (2020). Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints. Kidney International Reports. 5(8). 1302–1305.

17.

Ribeiro, Ana Cristina de Medeiros, Renata Miossi, Karina Rossi Bonfiglioli, et al.. (2020). Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area. Clinics. 75. e1870–e1870. 5 indexed citations

18.

Lopes, Michelle, Elenice Mantovani, Virgínia Lúcia Nazário Bonoldi, et al.. (2019). Anti-collagen type v: a marker of early systemic sclerosis?. Advances in Rheumatology. 59(1). 19–19. 6 indexed citations

19.

Lopes, Michelle, et al.. (2019). Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?. Clinical Rheumatology. 38(10). 2777–2783. 15 indexed citations

20.

Pons‐Estel, Bernardo A., Daniel Wojdyla, Graciela S. Alarcón, et al.. (2016). CE-45 Baseline factors predictive of the occurrence of neuropsychiatric damage accrual in latin american patients with systemic lupus erythematosus. A71.2–A72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact